Holen Sie sich die Stockscreener-App
4.92
5.13%
0.24
Handel nachbörslich:
4.92
Schlusskurs vom Vortag:
$4.68
Offen:
$4.85
24-Stunden-Volumen:
13,022
Relative Volume:
0.14
Marktkapitalisierung:
$27.68M
Einnahmen:
$257.00K
Nettoeinkommen (Verlust:
$-3.07M
KGV:
-5.1643
EPS:
-0.9527
Netto-Cashflow:
$-1.40M
1W Leistung:
+2.71%
1M Leistung:
+20.29%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$4.68
$4.95
1-Wochen-Bereich:
$4.3001
$4.95
52-Wochen-Spanne:
$4.00
$6.20
Optimi Health Corp Stock (OPTH) Company Profile
Compare OPTH vs TAK, HLN, TEVA, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPTH
Optimi Health Corp
|
4.92 | 26.33M | 257.00K | -3.07M | -1.40M | -0.9527 |
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Optimi Health Corp Aktie (OPTH) Neueste Nachrichten
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
OPTH|Optimi Health Ord Shs|Price:4.680|Chg%:-0.070 - TradingKey
Optimi Health (OPTH) CEO boosts stake with 18,700-share buy - Stock Titan
Optimi Health (OPTH) 10K Form and Latest SEC Filings 2026 - MarketBeat
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp - Yahoo! Finance Canada
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules - TMX Newsfile
3 Psychedelic Stocks With Potential Clinical Trial Catalysts - Sahm
OPTH Price Today: Optimi Health Corp. Stock Price, Quote & Chart - mexc.co
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia - AOL.com
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting - AOL.com
Optimi Health Corp. - The Canadian Securities Exchange (CSE)
Optimi Health Corp. (OPTH) Stock: Surges 8% as Psilocybin Shipments to Australia Signal Growing Commercial Momentum - parameter.io
Optimi Health completes psilocybin export to Australia for patients with treatment-resistant depression - MSN
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - Financial Times
Optimi Health (NASDAQ: OPTH) makes third psilocybin shipment for TRD - Stock Titan
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - GlobeNewswire Inc.
Optimi Health completes third export of psilocy... - Pluang
Price to earnings forward of Optimi Health Corp. – CSE:OPTI - TradingView
Price to sales forward of Optimi Health Corp. – LSX:A411WC - TradingView
Optimi Health Corp. (OPTH) Cash From Operations (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Market Cap - Zacks Investment Research
Optimi Health (OPTH) Stock Trends and Sentiment 2026 - MarketBeat
OPTH|Optimi Health Ord Shs|Price:4.060|Chg%:0.05 - TradingKey
Price to book ratio of Optimi Health Corp. – TRADEGATE:8BN0 - TradingView
Optimi Health Corp. (OPTH) Book Value - Zacks Investment Research
Optimi Health Corp. (OPTH) Earnings Yield (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Price To Free Cash Flow - Zacks Investment Research
Optimi Health Corp. (OPTH) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Optimi Health Corp. (OPTH) Free Cash Flow (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Total Expenses (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Shareholders Equity (Quarterly) - Zacks Investment Research
Optimi Health Corp. (OPTH) Net Income (Quarterly) - Zacks Investment Research
Optimi Health Corp. (OPTH) Ps Ratio (TTM) - Zacks Investment Research
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research - GuruFocus
Inside the new tiny-dose psilocybin pills labs will test in studies - Stock Titan
Optimi Health (OPTH) Earnings Date and Reports 2026 - MarketBeat
Optimi Health completes production of microdose psilocybin products By Investing.com - Investing.com Nigeria
Optimi Health completes production of microdose psilocybin products - Investing.com
Optimi Health (NASDAQ: OPTH) debuts standardized psilocybin microdose capsules for research - Stock Titan
Optimi Health launches 1mg and 2mg microdose ps... - Pluang
OPTH News | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel - Yahoo Finance
Optimi Health ships psilocybin to UK for clinical trial By Investing.com - Investing.com India
Finanzdaten der Optimi Health Corp-Aktie (OPTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.30%
2.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):